The Role of Anti-Glutamic Acid Decarboxylase Autoantibodies in Mood Disorders

Neuroimmunology and Neuroinflammation - United States
doi 10.4103/2347-8659.167300
Full Text
Abstract

Available in full text

Date
Authors
Publisher

OAE Publishing Inc.

Related search

Cerebellar Ataxia With Anti–Glutamic Acid Decarboxylase Antibodies

Archives of Neurology
2001English

Diabetes Mellitus and Ataxia With Anti-Glutamic Acid Decarboxylase Antibodies

Endocrine Abstracts
2016English

Cerebellar Ataxia Associated With Glutamic Acid Decarboxylase Autoantibody (Anti GAD)

Scholars Journal of Medical Case Reports
2020English

Effects of Anti-Glutamic Acid Decarboxylase Antibodies Associated With Neurological Diseases

Annals of Neurology
Neurology
2007English

Epilepsy and Cerebellar Ataxia Associated With Anti-Glutamic Acid Decarboxylase Antibodies

Journal of Neurology, Neurosurgery and Psychiatry
PsychiatryMental HealthNeurologySurgery
2007English

Clinical Characteristics of Anti-Glutamic Acid Decarboxylase Antibody-Positive Fulminant Type 1 Diabetes

Endocrine Journal
EndocrinologyMetabolismDiabetes
2019English

Detection of Autoantibodies Against Reactive Oxygen Species Modified Glutamic Acid Decarboxylase-65 in Type 1 Diabetes Associated Complications

BMC Immunology
Immunology
2011English

Identification of a Dominant Epitope of Glutamic Acid Decarboxylase (GAD-65) Recognized by Autoantibodies in Stiff-Man Syndrome

Journal of Experimental Medicine
MedicineAllergyImmunology
1993English

Human Autoantibodies React With Glutamic Acid Decarboxylase Antigen in Human and Rat but Not in Mouse Pancreatic Islets

Diabetologia
Internal MedicineEndocrinologyMetabolismDiabetes
1993English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy